Organogenesis Holdings Inc. (ORGO) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Organogenesis Holdings Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.032 Welcome ladies and gentlemen to the second quarter 2026 earnings conference call 00:00:05.032 -- 00:00:10.334 for Organogenesis Holdings Inc. At this time, all participants have been placed 00:00:10.334 -- 00:00:15.335 in listen-only mode. Please note that this conference call is being recorded and that 00:00:15.335 -- 00:00:20.497 the recording will be available on the company's website for replay shortly. 00:00:20.497 -- 00:00:25.438 Before we begin, I would like to remind everyone that our remarks today may contain forward-looking 00:00:25.438 -- 00:00:30.453 statements that are based on the current expectations of management and involve inherent 00:00:30.453 -- 00:00:35.716 risks and uncertainties that could cause actual results to differ materially from those 00:00:35.716 -- 00:00:40.760 indicated, including the risks and uncertainties described in the company's filings with 00:00:40.760 -- 00:00:45.783 the Securities and Exchange Commission, including item 1A, risk factors, of 00:00:45.783 -- 00:00:51.947 the company's most recent annual report and its subsequently filed quarterly reports. 00:00:51.947 -- 00:00:57.011 You are cautioned not to place undue reliance upon any forward-looking statements 00:00:57.011 -- 00:01:02.142 which speak only as of the date made. Although it may voluntarily do so from 00:01:02.142 -- 00:01:07.587 time to time, the company undertakes no commitment to update or revise the forward-looking 00:01:07.587 -- 00:01:13.092 statements, whether as a result of new information, future events, or otherwise, 00:01:13.092 -- 00:01:17.295 except as required by applicable securities laws. 00:01:17.295 -- 00:01:22.160 This call will also include references to certain financial measures that are not calculated ...